Relative mutagenic potencies of several nucleoside analogs, alone or in drug pairs, at the HPRT and TK loci of human TK6 lymphoblastoid cells
- 19 March 2007
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 48 (3-4) , 239-247
- https://doi.org/10.1002/em.20282
Abstract
Experiments were performed to investigate the impact of didanosine (ddI), lamivudine (3TC), and stavudine (d4T) on cell survival and mutagenicity in two reporter genes, hypoxanthine‐guanine phosphoribosyltransferase (HPRT) and thymidine kinase (TK), using a cell cloning assay for assessing the effects of individual nucleoside analogs (NRTIs)/drug combinations in human TK6 B‐lymphoblastoid cells. Three‐day treatments with 0, 33, 100, or 300 μM ddI, 3TC, or ddI‐3TC produced positive trends for increased HPRT and TK mutant frequencies. While dose‐related trends were too small to reach significance after treatments with d4T or d4T‐3TC, pairwise comparisons with control cells indicated that exposure to 100 μM d4T or d4T‐3TC caused significant elevations in HPRT mutants. Measurements of mutagenicity in cells exposed to d4T (or d4T‐3TC) were complicated by the cytotoxicity of this NRTI. Enhanced increases in mutagenic responses to combined NRTI treatments, compared with single drug treatments, occurred as additive to synergistic effects in the HPRT gene of cells exposed to 100 μM ddI‐3TC or 100 μM d4T‐3TC, and in the TK gene of cells exposed to 100 or 300 μM ddI‐3TC. Comparisons of these data to mutagenicity studies of other NRTIs in the same system (Meng Q et al. [2000c]: Proc Natl Acad Sci USA 97:12667–126671; Torres SM et al. [2007]: Environ Mol Mutagen) indicate that the relative mutagenic potencies for all drugs tested to date are: AZT‐ddI > ddI‐3TC > AZT‐3TC ≅ AZT‐3TC‐ABC (abacavir) > AZT ≥ddI > d4T‐3TC > 3TC > d4T ≥ ABC. These collective data suggest that all NRTIs with antiviral activity against HIV‐1 may cause host cell DNA damage and mutations, and impose a cancer risk. Environ. Mol. Mutagen., 2007.Keywords
This publication has 32 references indexed in Scilit:
- Clinical mitochondrial dysfunction in uninfected children born to HIV‐infected mothers following perinatal exposure to nucleoside analoguesEnvironmental and Molecular Mutagenesis, 2007
- Transplacental carcinogenicity of 3′‐azido‐3′‐deoxythymidine in B6C3F1 mice and F344 ratsEnvironmental and Molecular Mutagenesis, 2007
- Genotoxicity assessed by the comet and GPA assays following in vitro exposure of human lymphoblastoid cells (H9) or perinatal exposure of mother–child pairs to AZT or AZT‐3TCEnvironmental and Molecular Mutagenesis, 2007
- Mutagenicity of zidovudine, lamivudine, and abacavir following in vitro exposure of human lymphoblastoid cells or in utero exposure of CD‐1 mice to single agents or drug combinationsEnvironmental and Molecular Mutagenesis, 2007
- Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother‐to‐child transmission of HIVEnvironmental and Molecular Mutagenesis, 2007
- Plasma and cellular markers of 3′‐azido‐3′‐dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIsEnvironmental and Molecular Mutagenesis, 2007
- Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cellsMutagenesis, 2005
- Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugsToxicology and Applied Pharmacology, 2004
- Hprt mutant frequencies in splenic T‐cells of male F344 rats exposed by inhalation to propyleneEnvironmental and Molecular Mutagenesis, 2004
- Mutation assay at the thymidine kinase locus in diploid human lymphoblastsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1982